Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




New Detection Cartridges Expand Modular Platform Applications

By LabMedica International staff writers
Posted on 18 Feb 2009
Four new cartridges for a bioresearch detection platform increase the total number of interchangeable choices to 14, extending platform utility for users of the multimode reader.

The new options for Beckman Coulter's (Fullerton, CA, USA) Paradigm Detection Platform include two additional luminescence detection cartridges optimized for 96- and 384-well plate formats, a new detection cartridge for BRET2 (Bioluminescence Resonance Energy Transfer) live cell assays, and a Rhodamine fluorescence cartridge for a selection of cyanine dyes.

Two of the four new detection cartridges expand the platform's Glow Luminescence line with options designed for 96- and 384-well applications, complementing the existing Glow Luminescence Detection Cartridge optimized for the 1536-well plate format. More...
The well-isolating design of each cartridge is optimized for a specific plate format to provide increased sensitivity with reduced cross talk.

Ideal for the study of protein-protein interactions, the Dual Luminescence Detection Cartridge is optimized for use with BRET2 live cell assays and includes predefined protocols and data analysis tools.

The Fluorescence Intensity Detection Cartridge delivers speed and high sensitivity in applications using Cy3 and equivalent Rhodamine fluorescent labels. This new cartridge expands Beckman Coulter's detection menu for FRET (Fluorescence Resonance Energy Transfer) assays by reading Cy3 paired with Cy5 or Cy5.5 dyes, which are commonly used in genomics and proteomics research.

"The Paradigm platform has been very well-received since its introduction last year and customers value its modularity," explained Alisa Jackson, product manager for Beckman Coulter. "With these new cartridges and others that were previously added, we've almost doubled the detection choices since introduction. We will continue to add cartridges for relevant applications."

Related Links:

Beckman Coulter





Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.